TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on

Cora N Sternberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.